stockrow
Friday 6 November 2026
Export KOD’s income statement to Excel — free account
Kodiak Sciences Inc.
- EPS
- −1.94%
- Free cash flow
- −33.9%
Quarter to June 2026, against a year earlier
98.85
7.83
+8.60%
Follow KOD
Alert me
Kodiak Sciences Inc. (KOD) Book value per share
Kodiak Sciences Inc.'s book value per share at the end of fiscal 2025 was 3.0×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 1.0×. Over the past ten years it has ranged from −9.1× (fiscal 2017) to 18.8× (fiscal 2020); the current reading is higher than 40% of that period. Kodiak Sciences Inc. ranks 350th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 3.0× | 3.49% |
| FY2024 | 2.9× | (43.64%) |
| FY2023 | 5.1× | (39.26%) |
| FY2022 | 8.3× | (34.82%) |
| FY2021 | 12.8× | (31.94%) |
| FY2020 | 18.8× | 106.26% |
| FY2019 | 9.1× | 57.36% |
| FY2018 | 5.8× | — |
| FY2017 | −9.1× | — |
| FY2016 | −5.7× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 1.0× | (46.17%) |
| Mar 2026 | 1.8× | (38.73%) |
| Dec 2025 | 3.0× | 559.95% |
| Sep 2025 | 0.4× | (66.35%) |
| 32 more quarters | Free account |
Against its own ten years
Low −9.1×
High 18.8×
Ten-year median
5.4×
Current reading's percentile
40
Book value per share against peers
| Company | Book value per share |
|---|---|
| LGND Ligand Pharmaceuticals Incorporated compare | 48.2× |
| BLTE Belite Bio, Inc. Sponsored ADR compare | 19.3× |
| ORKA Oruka Therapeutics, Inc. compare | 17.7× |
| CGON CG Oncology, Inc. compare | 11.7× |
| IMVT Immunovant, Inc. compare | 3.6× |
| IONS Ionis Pharmaceuticals, Inc. compare | 2.7× |
| KOD Kodiak Sciences Inc. | 1.0× |
| MIRM Mirum Pharmaceuticals, Inc. compare | −0.8× |
| PTCT PTC Therapeutics, Inc. compare | −2.3× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))